Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Category: Research
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...
Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
New insights into the neurologic and physiologic impact of chronic stress on ovarian cancer were presented at two recent...